Literature DB >> 7532799

Phosphorylethanolamine content of human brain tumors.

Y Kinoshita1, A Yokota, Y Koga.   

Abstract

Phosphorylethanolamine (PEA) is the major component of the phosphomonoester peak detected by phosphorus-31 magnetic resonance spectroscopy, but the absolute concentration has not been determined. This study measured the PEA concentration in biopsy specimens of brain tumors and lobectomized cerebral cortex using high-performance liquid chromatography. The concentration of PEA was 118.5 +/- 10.0 mumol/100 g wet wt in cortex, and was significantly higher in malignant gliomas, metastatic pulmonary adenocarcinoma, and neurinoma. The concentration of PEA was especially high in pituitary adenoma, malignant lymphoma, and medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532799     DOI: 10.2176/nmc.34.803

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  5 in total

1.  In Vivo Neurochemical Characterization of Developing Guinea Pigs and the Effect of Chronic Fetal Hypoxia.

Authors:  Wen-Tung Wang; Phil Lee; Yafeng Dong; Hung-Wen Yeh; Jieun Kim; Carl P Weiner; William M Brooks; In-Young Choi
Journal:  Neurochem Res       Date:  2016-05-27       Impact factor: 3.996

2.  In vivo spectral editing of phosphorylethanolamine.

Authors:  Steve C N Hui; Helge J Zöllner; Georg Oeltzschner; Richard A E Edden; Muhammad G Saleh
Journal:  Magn Reson Med       Date:  2021-08-19       Impact factor: 4.668

3.  Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.

Authors:  Sanjeev Chawla; Sungheon Kim; Laurie A Loevner; Harry Quon; Sumei Wang; Faith Mutale; Gregory Weinstein; Edward J Delikatny; Harish Poptani
Journal:  Acad Radiol       Date:  2009-07-15       Impact factor: 3.173

4.  Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.

Authors:  Elke Hattingen; Oliver Bähr; Johannes Rieger; Stella Blasel; Joachim Steinbach; Ulrich Pilatus
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

Review 5.  Metabolomics-A Promising Approach to Pituitary Adenomas.

Authors:  Oana Pînzariu; Bogdan Georgescu; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.